Avidity Biosciences (RNA) Earnings Date & Reports

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RNA is expected to report earnings to rise 9.41% to -87 cents per share on May 13

Avidity Biosciences RNA Stock Earnings Reports

Q1'25

Est.

$-0.88

Q4'24

Est.

$-0.80

Q3'24

Beat

by $0.06

Q2'24

Beat

by $0.19

Q1'24

Beat

by $0.02

The last earnings report on February 27 showed earnings per share of -80 cents, meeting the estimate of -80 cents. With 132.51K shares outstanding, the current market capitalization sits at 3.80B.

View a ticker or compare two or three

Compare

RNA